Notice2026-07150
National Heart, Lung, And Blood Institute; Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
April 14, 2026
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 71 (Tuesday, April 14, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 71 (Tuesday, April 14, 2026)]
[Notices]
[Page 19144]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-07150]
[[Page 19144]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, And Blood Institute; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Sickle Cell Disease
Advisory Committee.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting. The open session will be videocast and can be
accessed from the NIH Videocasting and Podcasting website (<a href="https://videocast.nih.gov/watch/d3614358-26f0-11f1-9f14-124f0a52e769">https://videocast.nih.gov/watch/d3614358-26f0-11f1-9f14-124f0a52e769</a>).
Name of Committee: Sickle Cell Disease Advisory Committee
(SCDAC).
Date: May 26, 2026.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: Nutrition in Sickle Cell Disease.
Address: National Institutes of Health, 6705 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Julie A Panepinto, MD, MSPH, Professor, DFO/
Executive Secretary, SCDAC, Division of Blood Diseases and
Resources, 6701 Rockledge Drive, Suite 9166, Bethesda, MD 20892,
(301) 435-0080, <a href="/cdn-cgi/l/email-protection#1d5768717478336d7c73786d747369725d737475337a726b"><span class="__cf_email__" data-cfemail="de94abb2b7bbf0aebfb0bbaeb7b0aab19eb0b7b6f0b9b1a8">[email protected]</span></a>.
Registration is not required to attend the open portion of this
meeting.
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
Information is also available on the Institute's/Center's home
page: <a href="https://www.nhlbi.nih.gov/advisory-and-peer-review-committees/nhlbi-sickle-cell-disease-advisory-committee">https://www.nhlbi.nih.gov/advisory-and-peer-review-committees/nhlbi-sickle-cell-disease-advisory-committee</a>, where an agenda and any
additional information for the meeting will be posted when available.
Dated: April 9, 2026.
Denise M. Santeufemio,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2026-07150 Filed 4-13-26; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js" defer></script></body>
</html>Indexed from Federal Register on April 14, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.